Back to search
FDAFDA · Food and drugs·Recall number D-0050-2027

Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01

Published October 28, 2026 · Recall initiated: October 1, 2026

Summary

FDA records drug Class II recall D-0050-2027, published October 28, 2026 and initiated October 1, 2026. Recalling firm: Shenzhen Techdow Pharmaceutical Co., Ltd.; Status: Ongoing; Reported quantity: 251,000 1 mL multidose vials; Lot: Lot# CU03232A, Exp 1/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email if HEPARIN SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HEPARIN SODIUM
Manufacturer
Shenzhen Techdow Pharmaceutical Co., Ltd.
Distributor
Nationwide in the USA.
UPC
0381952113018
Lot
Lot# CU03232A, Exp 1/31/2028
Risk classification
Class II
Area (FDA)
drug
Country
China

Related recalls

Questions about this recall

Was Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01 recalled?

Yes. FDA published recall D-0050-2027 on October 28, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HEPARIN SODIUM. UPC: 0381952113018.